Publication:
Pulmonary thromboendarterectomy in a combined thrombophilia patient.

Placeholder

Organizational Units

Program

Authors

Authors

Akbayrak, Hakan
Tekumit, Hayrettin

Advisor

Date

Language

Type

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is a potentially correctable cause of secondary pulmonary hypertension. Surgical treatment remains the primary treatment for patients with CTEPH. Pulmonary thromboendarterectomy (PEA) with deep hypothermic circulatory arrest is the standard and recommended surgical technique for the treatment of these patients. The prevalence of CTEPH after an acute pulmonary thromboembolism (PTE) has been found in various studies to be between 0.6 and 8.8%. Mortality rates in elective PEA cases with CTEPH are reported to be between 1.9 and 4.5%. We report on a 50-year-old female patient with combined inherited thrombophilia, including protein C and protein S deficiencies, who was diagnosed with CTEPH and was successfully treated with pulmonary thromboendarterectomy.

Description

Source:

Keywords:

Citation

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads


Sustainable Development Goals